# FDA recall D-0555-2023

> **SCA Pharmaceuticals** · Class III · drug recall initiated 2023-04-10.

## Product

Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44

## Reason for recall

Subpotent Drug: Out of specification results for low potency was obtained.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0555-2023
- **Recalling firm:** SCA Pharmaceuticals
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-04-10
- **Report date:** 2023-05-03
- **Termination date:** 2023-09-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Windsor, CT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0555-2023

## Citation

> AI Analytics. FDA recall D-0555-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0555-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*